- Home
- OCUL vs FORTY Comparison
OCUL vs FORTY Comparison
Compare OCUL & FORTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCUL
- FORTY
- Stock Information
- Founded
- OCUL 2006
- FORTY 1985
- Country
- OCUL United States
- FORTY Israel
- Employees
- OCUL N/A
- FORTY N/A
- Industry
- OCUL Biotechnology: Pharmaceutical Preparations
- FORTY EDP Services
- Sector
- OCUL Health Care
- FORTY Technology
- Exchange
- OCUL Nasdaq
- FORTY Nasdaq
- Market Cap
- OCUL 2.3B
- FORTY 2.3B
- IPO Year
- OCUL 2014
- FORTY 1997
- Fundamental
- Price
- OCUL $12.24
- FORTY $161.05
- Analyst Decision
- OCUL Strong Buy
- FORTY
- Analyst Count
- OCUL 10
- FORTY 0
- Target Price
- OCUL $22.33
- FORTY N/A
- AVG Volume (30 Days)
- OCUL 2.1M
- FORTY 563.0
- Earning Date
- OCUL 11-04-2025
- FORTY 11-20-2025
- Dividend Yield
- OCUL N/A
- FORTY 0.91%
- EPS Growth
- OCUL N/A
- FORTY 15.06
- EPS
- OCUL N/A
- FORTY 4.97
- Revenue
- OCUL $55,783,000.00
- FORTY $2,889,481,000.00
- Revenue This Year
- OCUL N/A
- FORTY N/A
- Revenue Next Year
- OCUL $17.75
- FORTY N/A
- P/E Ratio
- OCUL N/A
- FORTY $29.94
- Revenue Growth
- OCUL N/A
- FORTY 8.58
- 52 Week Low
- OCUL $5.79
- FORTY $80.15
- 52 Week High
- OCUL $13.85
- FORTY $169.03
- Technical
- Relative Strength Index (RSI)
- OCUL 59.26
- FORTY 68.93
- Support Level
- OCUL $11.08
- FORTY $137.45
- Resistance Level
- OCUL $12.03
- FORTY $148.00
- Average True Range (ATR)
- OCUL 0.53
- FORTY 1.85
- MACD
- OCUL 0.13
- FORTY 1.16
- Stochastic Oscillator
- OCUL 89.86
- FORTY 78.88
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
About FORTY Formula Systems (1985) Ltd.
Formula Systems (1985) Ltd is a holding company that, through its subsidiaries, provides information technology services. The company organizes itself into operating segments: The Matrix segment, which generates the majority of revenue, provides software development and existing software expansion services. The Sapiens segment provides software development services for the insurance industry. The Magic Software segment provides vendor management systems and workforce management services, which include accounting and finance, human resources, Michpal, ZAP Group, and Others. The majority of the company's revenue comes from Israel.